Company intelligence / Profile preview

Unitas Capital

Ownership: Private
Employees: ~9
Development stage: Other

Overview

Unitas Capital was a Hong Kong-headquartered private equity firm specializing in buyouts and growth capital investments across Asia, particularly targeting medium-to-large companies in the branded consumer, retail, and industrial sectors. The firm has invested in more than 30 companies across Australia, New Zealand, China, Korea, Japan, and Singapore. As of 2016–2020s it has been winding down operations after abandoning new fundraising efforts; its China team joined Permira under a transition agreement[1][2][3][4].

Industry: Investors

Beyond the preview

Go deeper on Unitas Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Unitas Capital.

Explore the full profile